Pliant Therapeutics (PLRX) FCF Margin (2020 - 2023)
Pliant Therapeutics (PLRX) reported FCF Margin of 10226.61% for Q2 2023, down 975053.0% year-over-year from N/an in Q2 2022, and down 347.51% quarter-over-quarter from 2285.21% in Q1 2023.
Pliant Therapeutics (PLRX) FCF Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of FCF Margin data on file, last reported at 10226.61% in Q2 2023.
- FCF Margin for Q2 2023 came in at 10226.61%, down 975053.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 47825.0% (down 4676104.0% YoY), and the FY2023 annual result was 7422.91%, down 644582.0% from the prior year.
- FCF Margin declined to 10226.61% in Q2 2023 per PLRX's latest filing, from 2285.21% in the prior quarter.
- Over five years, FCF Margin peaked at 207.94% in Q2 2020 and troughed at 10226.61% in Q2 2023.
- A 4-year average of 1585.05% and a median of 1002.07% in 2021 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2023: FCF Margin soared 59954 bps in 2022, then plunged 975053 bps in 2023.
- A 4-year view of FCF Margin shows it stood at 352.25% in 2020, then plunged by 164 bps to 928.51% in 2021, then plunged by 62 bps to 1508.65% in 2022, then slumped by 578 bps to 10226.61% in 2023.
- Business Quant data shows PLRX's FCF Margin at 10226.61% in Q2 2023, 2285.21% in Q1 2023, and 1508.65% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -10,226.61% |
| Mar 31, 2023 | -2,285.21% |
| Dec 31, 2022 | -1,508.65% |
| Sep 30, 2022 | -1,355.74% |
| Jun 30, 2022 | -476.09% |
| Mar 31, 2022 | -1,692.71% |
| Dec 31, 2021 | -928.51% |
| Sep 30, 2021 | -1,477.58% |
| Jun 30, 2021 | -1,075.63% |
| Mar 31, 2021 | -639.70% |
| Dec 31, 2020 | -352.25% |
| Sep 30, 2020 | -334.75% |
| Jun 30, 2020 | 207.94% |
| Mar 31, 2020 | -45.28% |